Form 4: OneMedNet CFO Golden Boosts Stake with Significant RSU Grants

OneMedNet Corp's Chief Financial Officer and Director, Robert Lawrence Golden, reported multiple acquisitions of common stock and restricted stock units, significantly increasing his beneficial ownership.

Summary

• Robert Lawrence Golden, Chief Financial Officer and Director of OneMedNet Corp, reported several transactions increasing his beneficial ownership.
• On December 7, 2023, Golden acquired 300 shares of common stock at a price of $1.71 per share.
• On January 19, 2024, he was granted 45,000 restricted stock units (RSUs) as director compensation for fiscal year 2024, which vested on December 31, 2024.
• On August 30, 2024, Golden received 100,000 RSUs pursuant to a consulting agreement, vesting on August 30, 2025.
• On January 31, 2025, 24,272 RSUs were granted in lieu of a cash bonus related to his appointment as permanent Chief Financial Officer, which fully vested on the grant date.
• On November 24, 2025, two separate RSU grants were made: 300,000 RSUs vesting with 1/3 on January 1, 2026, and the remainder in equal quarterly installments over 24 months; and 33,333 RSUs vesting in full on December 31, 2025.
• On November 26, 2025, an additional 45,000 RSUs were granted as director compensation for fiscal year 2025, vesting on December 31, 2025.
• Following these reported transactions, Robert Lawrence Golden beneficially owns a total of 547,905 shares of OneMedNet Corp common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. Significant RSU grants and a small direct stock purchase by a key executive indicate strong insider confidence and alignment of interests with shareholders. However, it's a compensation report, not a performance report, so the positive sentiment is limited to insider activity rather than operational results.

Positives

• Significant increase in beneficial ownership by a key executive (CFO and Director), indicating strong insider confidence in the company's future.
• Equity grants align the interests of management with those of shareholders, as a substantial portion of the CFO's compensation is tied to the company's stock performance.
• The acquisition of 300 shares at $1.71 represents a direct cash investment by the insider.

Negatives

• The majority of the acquired securities are Restricted Stock Units (RSUs) granted at a price of $0.00, meaning no direct cash investment was made for these shares by the insider at the time of grant.

Risks

• Vesting of RSUs is subject to the reporting person's continued service with the issuer through each vesting date, meaning the shares are not fully owned until these conditions are met.
• The value of the RSUs is dependent on the future market price of OneMedNet Corp's common stock, exposing the holder to market volatility.

Future Outlook

The future outlook for Robert Lawrence Golden's beneficial ownership includes the vesting of several tranches of Restricted Stock Units on various dates through December 31, 2025, and beyond, subject to his continued service with OneMedNet Corp.

Industry Context

This Form 4 filing is a standard disclosure of insider transactions and does not provide broader industry context or trends. It reflects company-specific compensation and ownership changes for a key executive.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of the Chief Financial Officer's financial interests with shareholder value through significant equity ownership.
• Employees: The RSU grants are part of executive compensation, which can influence overall compensation philosophy and morale.

Next Steps

• Continued service of Robert Lawrence Golden with OneMedNet Corp to ensure vesting of future RSU grants.
• Future disclosures of beneficial ownership changes by Robert Lawrence Golden as additional RSUs vest or other transactions occur.

Key Dates

Recommendation

The significant increase in beneficial ownership by a key executive through RSU grants and a direct stock purchase is a positive signal of insider confidence. This aligns management's interests with shareholders, which is generally favorable. However, a Form 4 filing primarily reports transactions and does not provide comprehensive financial or operational data to warrant a 'buy' or 'sell' recommendation. A 'hold' is appropriate, acknowledging the positive insider activity while awaiting further fundamental analysis of the company's performance and prospects.

Keywords

OneMedNet Corp, ONMD, Robert Lawrence Golden, Form 4, insider trading, restricted stock units, RSU, beneficial ownership, CFO, director compensation, equity incentive plan